BIOE — Bio Essence Cashflow Statement
0.000.00%
Last trade - 00:00- $12.82m
- $12.88m
- $1.90m
Annual cashflow statement for Bio Essence, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.648 | -0.528 | -0.803 | -1.31 | 0.896 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.237 | 0.02 | 0.182 | 1.11 | 0.042 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.919 | -0.21 | -0.423 | 0.819 | 0.631 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -1.29 | -0.703 | -1.03 | 0.624 | 1.57 |
| Capital Expenditures | -0.119 | -0.004 | -0.004 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.003 | -0.055 | -0.088 | -0 | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.117 | -0.059 | -0.091 | -0 | — |
| Financing Cash Flow Items | 0 | -0.067 | -0.036 | -0.009 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.41 | 0.768 | 1.11 | -0.622 | -1.57 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.005 | 0.006 | -0.006 | 0.001 | -0.001 |